Trading Window Closure from October 1 for Q2 FY26 Results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹30.40

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-1.0% vs market

Pharmaceuticals peers, median of 172sector-1.5%-1.2% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6-1.6-1.0-1.5-1.2

Next day

-1.7-0.6-1.2-1.0-0.8

-3.6-0.8-2.8-1.9-1.7

-0.8-2.1+1.3-2.5+1.6

-0.8-2.1+1.3-3.4+2.5

-2.4-0.8-1.6-2.4-0.0

+0.3-3.8+4.1-4.3+4.6

15d

-3.9-6.9+3.0-7.9+3.9

-10.2-8.0-2.2-6.4-3.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pharmaids Pharmaceuticals has closed its trading window from October 1, 2026 until 48 hours after the declaration of unaudited financial results for Q2 and H1 FY26 ending September 30, 2026. The closure applies to designated persons and their immediate relatives under SEBI insider trading norms. The board meeting date to approve Q2 results will be announced later.

Likely market impact

Insiders cannot trade shares until Q2 FY26 results are declared. Signals upcoming earnings announcement; expect volatility around results.